DekaBank Deutsche Girozentrale’s TherapeuticsMD TXMD Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,390	Closed	-$50K	–	1482
2021 Q3	$50K	Hold	1,390	–	–	﹤0.01%	1331
2021 Q2	$81K	Hold	1,390	–	–	﹤0.01%	1335
2021 Q1	$94K	Hold	1,390	–	–	﹤0.01%	1286
2020 Q4	$81K	Hold	1,390	–	–	﹤0.01%	1282
2020 Q3	$110K	Buy	+1,390	New	+$111K	﹤0.01%	1121
2019 Q4	–	Sell	-1,430	Closed	-$270K	–	1225
2019 Q3	$270K	Sell	1,430 -1,430	-50%	-$202K	﹤0.01%	822
2019 Q2	$359K	Buy	2,860 +1,110	+63%	+$199K	﹤0.01%	957
2019 Q1	$564K	Buy	1,750 +320	+22%	+$84.7K	﹤0.01%	884
2018 Q4	$283K	Sell	1,430 -320	-18%	-$78.1K	﹤0.01%	923
2018 Q3	$564K	Sell	1,750 -50	-3%	-$15.3K	﹤0.01%	904
2018 Q2	$600K	Hold	1,800	–	–	﹤0.01%	869
2018 Q1	$455K	Buy	+1,800	New	+$505K	﹤0.01%	881

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DekaBank Deutsche Girozentrale's TXMD Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of TherapeuticsMD (TXMD) in Q4 2021, closing a stake of 1,390 shares — an estimated $50K sold.

DekaBank Deutsche Girozentrale first reported a position in TXMD in Q1 2018 and held it in 12 quarters. The position peaked at $600K in Q2 2018. 131 funds tracked by Wall St. Rank hold TXMD as of Q4 2021.

DekaBank Deutsche Girozentrale reported no remaining TherapeuticsMD position as of Q4 2021 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 1,390 TherapeuticsMD shares in Q4 2021, an estimated $50K.
DekaBank Deutsche Girozentrale first reported a position in TherapeuticsMD in Q1 2018 and held it in 12 quarters.
DekaBank Deutsche Girozentrale's TherapeuticsMD position peaked at $600K in Q2 2018.
131 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.